These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29253144)

  • 1. Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.
    Voigt EA; Haralambieva IH; Larrabee BL; Kennedy RB; Ovsyannikova IG; Schaid DJ; Poland GA
    J Infect Dis; 2018 Jan; 217(4):560-566. PubMed ID: 29253144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients.
    Kennedy RB; Ovsyannikova IG; Haralambieva IH; Lambert ND; Pankratz VS; Poland GA
    Immunogenetics; 2014 Aug; 66(7-8):493-9. PubMed ID: 24811271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination.
    Kennedy RB; Ovsyannikova IG; Haralambieva IH; Lambert ND; Pankratz VS; Poland GA
    Hum Genet; 2014 Nov; 133(11):1407-17. PubMed ID: 25098560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination.
    Lambert ND; Haralambieva IH; Kennedy RB; Ovsyannikova IG; Pankratz VS; Poland GA
    J Infect Dis; 2015 Mar; 211(6):898-905. PubMed ID: 25293367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.
    Haralambieva IH; Ovsyannikova IG; Umlauf BJ; Vierkant RA; Shane Pankratz V; Jacobson RM; Poland GA
    Vaccine; 2011 Nov; 29(48):8988-97. PubMed ID: 21939710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.
    Ovsyannikova IG; Salk HM; Larrabee BR; Pankratz VS; Poland GA
    Immunogenetics; 2015 Oct; 67(10):547-61. PubMed ID: 26329766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination.
    Haralambieva IH; Lambert ND; Ovsyannikova IG; Kennedy RB; Larrabee BR; Pankratz VS; Poland GA
    PLoS One; 2014; 9(6):e99997. PubMed ID: 24945853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population.
    Dhiman N; Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Tissue Antigens; 2008 Sep; 72(3):211-20. PubMed ID: 18715339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide determinants of cellular immune responses to mumps vaccine.
    Ovsyannikova IG; Haralambieva IH; Schaid DJ; Warner ND; Poland GA; Kennedy RB
    Vaccine; 2023 Oct; 41(44):6579-6588. PubMed ID: 37778899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.
    Crooke SN; Ovsyannikova IG; Kennedy RB; Warner ND; Poland GA
    Vaccine; 2020 Nov; 38(50):7897-7904. PubMed ID: 33158591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.
    Dhiman N; Ovsyannikova IG; Ryan JE; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
    Clin Exp Immunol; 2005 Dec; 142(3):498-504. PubMed ID: 16297162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional signatures associated with rubella virus-specific humoral immunity after a third dose of MMR vaccine in women of childbearing age.
    Haralambieva IH; Eberhard KG; Ovsyannikova IG; Grill DE; Schaid DJ; Kennedy RB; Poland GA
    Eur J Immunol; 2021 Jul; 51(7):1824-1838. PubMed ID: 33818775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
    Madi N; Altawalah H; Alfouzan W; Al-Nakib W; Al-Roumi E; Jeragh A
    J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes.
    White SJ; Haralambieva IH; Ovsyannikova IG; Vierkant RA; O'Byrne MM; Poland GA
    Hum Immunol; 2012 Jun; 73(6):636-40. PubMed ID: 22504412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.
    Haralambieva IH; Ovsyannikova IG; Kennedy RB; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Vaccine; 2011 Oct; 29(45):7883-95. PubMed ID: 21875636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
    Haralambieva IH; Ovsyannikova IG; Kennedy RB; Goergen KM; Grill DE; Chen MH; Hao L; Icenogle J; Poland GA
    Vaccine; 2020 Jan; 38(5):1249-1257. PubMed ID: 31732325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
    Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
    Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children.
    Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
    Clin Immunol; 2005 May; 115(2):154-61. PubMed ID: 15885638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
    Knuf M; Zepp F; Helm K; Maurer H; Prieler A; Kieninger-Baum D; Douha M; Willems P
    Eur J Pediatr; 2012 Mar; 171(3):463-70. PubMed ID: 21935584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.
    Ovsyannikova IG; Salk HM; Larrabee BR; Pankratz VS; Poland GA
    Immunogenetics; 2014 Nov; 66(11):663-9. PubMed ID: 25139337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.